Details
Stereochemistry | ACHIRAL |
Molecular Formula | C17H28N2O2.ClH |
Molecular Weight | 328.877 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CCCCNC1=CC=C(C=C1)C(=O)OCCN(CC)CC
InChI
InChIKey=XTIUAXFQEAMQRU-UHFFFAOYSA-N
InChI=1S/C17H28N2O2.ClH/c1-4-7-12-18-16-10-8-15(9-11-16)17(20)21-14-13-19(5-2)6-3;/h8-11,18H,4-7,12-14H2,1-3H3;1H
Molecular Formula | C17H28N2O2 |
Molecular Weight | 292.4164 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: http://www.genome.jp/dbget-bin/www_bget?dr:D01967https://www.ncbi.nlm.nih.gov/pubmed/26302690Curator's Comment: description was created based on several sources, including:
https://www.ncbi.nlm.nih.gov/pubmed/10551118
Sources: http://www.genome.jp/dbget-bin/www_bget?dr:D01967https://www.ncbi.nlm.nih.gov/pubmed/26302690
Curator's Comment: description was created based on several sources, including:
https://www.ncbi.nlm.nih.gov/pubmed/10551118
p-Butylaminobenzoyldiethylaminoethyl hydrochloride (T-cain) was the most frequently used local anesthetic for spinal anesthesia in Japan in the 1940s–1960s. The market for spinally administered T-cain is almost ended. T-cain is still used for topical/infiltrative anesthesia in some specialties. T-cain may also be used as an alternative in patients who are allergic to lidocaine or bupivacaine. The side effects reported for spinal use of Neo Percamin S (T-cain with dibucaine) were hypotension, bradycardia, respiratory arrest, and allergy.
CNS Activity
Sources: http://www.genome.jp/dbget-bin/www_bget?dr:D01967
Curator's Comment: Agents affecting nervous system and sensory organs, agents affecting peripheral nervous system
Originator
Approval Year
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sources: https://www.ncbi.nlm.nih.gov/pubmed/26302690 |
Palliative | Neo-Percamin S Approved UseT-cain was approved in May 1950 for spinal use. the use of T-cain for topical and/or infiltrative use has been expanding in otorhynolaryngology and ophthalmology. |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:29:31 GMT 2023
by
admin
on
Fri Dec 15 15:29:31 GMT 2023
|
Record UNII |
5TL4JR7MPF
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
27891
Created by
admin on Fri Dec 15 15:29:31 GMT 2023 , Edited by admin on Fri Dec 15 15:29:31 GMT 2023
|
PRIMARY | |||
|
5TL4JR7MPF
Created by
admin on Fri Dec 15 15:29:31 GMT 2023 , Edited by admin on Fri Dec 15 15:29:31 GMT 2023
|
PRIMARY | |||
|
CHEMBL612029
Created by
admin on Fri Dec 15 15:29:31 GMT 2023 , Edited by admin on Fri Dec 15 15:29:31 GMT 2023
|
PRIMARY | |||
|
16488-48-5
Created by
admin on Fri Dec 15 15:29:31 GMT 2023 , Edited by admin on Fri Dec 15 15:29:31 GMT 2023
|
PRIMARY | |||
|
DTXSID4048777
Created by
admin on Fri Dec 15 15:29:31 GMT 2023 , Edited by admin on Fri Dec 15 15:29:31 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
|